PRIMARY GASTROINTESTINAL LYMPHOMAS IN TURKEY - A RETROSPECTIVE ANALYSIS OF CLINICAL-FEATURES AND RESULTS OF TREATMENT

DINCOL D., ICLI F., EREKUL S., GUNEL N., KARAOGUZ H., DEMİRKAZIK A.

JOURNAL OF SURGICAL ONCOLOGY, vol.51, no.4, pp.270-273, 1992 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 51 Issue: 4
  • Publication Date: 1992
  • Doi Number: 10.1002/jso.2930510414
  • Journal Name: JOURNAL OF SURGICAL ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.270-273
  • Keywords: GASTROINTESTINAL SYSTEM, LYMPHOMA, EPIDEMIOLOGY, SURGERY, CHEMOTHERAPY, NON-HODGKINS LYMPHOMA, MIDDLE-EAST, SURGERY, TRACT, CLASSIFICATION, CHEMOTHERAPY, INVOLVEMENT, DISEASE, IE
  • Lokman Hekim University Affiliated: No

Abstract

Thirty-three patients with primary gastrointestinal lymphoma (GIL) followed at Ankara University Medical School have been evaluated. The most frequent locations of the disease are the small intestine (48.4%) and the stomach (39.3%). The intermediate and high grade lymphomas constitute 84.8% of the cases. The mean age of the patients with small intestinal lymphoma is 28.7 years and 47.1 years for those with gastric lymphoma. The patients treated with surgery and chemotherapy (S + CT) have a longer survival than those treated with chemotherapy (CT) alone. In conclusion: 1) Small intestinal lymphoma occurs more frequently than gastric lymphoma in our study. 2) The median age of the Turkish patients with primary GIL is approximately 10 years less than those in the Western countries. 3) The therapeutic results of S + CT are superior to those of CT in the early stages of the disease.